查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655473

纤维蛋白胶的全球市场

Fibrin Sealants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 92 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球纤维蛋白胶市场规模将达到 16 亿美元

2024 年全球纤维蛋白胶市场规模估计为 11 亿美元，预计 2030 年将达到 16 亿美元，2024 年至 2030 年的复合年增长率为 6.1%。纤维蛋白胶液是报告中分析的细分市场之一，预计复合年增长率为 6.4%，到分析期结束时将达到 12 亿美元。在分析期内，纤维蛋白胶贴片部分预计将以 5.4% 的复合年增长率成长。

美国市场规模估计为 2.931 亿美元，中国市场预期复合年增长率为 9.1%

预计 2024 年美国纤维蛋白胶市值将达 2.931 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 3.641 亿美元，2024-2030 年分析期间的复合年增长率为 9.1%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 3.3% 和 5.9%。在欧洲，德国的复合年增长率预计为 3.7%。

全球纤维蛋白胶市场-主要趋势与驱动因素摘要

什么是纤维蛋白胶？

纤维蛋白胶是一种生物黏合剂，用于各种医疗应用，促进创伤治疗和组织修復。此密封剂由纤维蛋白原和凝血酶组成，模拟血液凝固过程的最后步骤，促进纤维蛋白凝块的形成，有效密封伤口并促进止血。纤维蛋白胶广泛应用于各种外科手术，包括一般外科手术、整形外科手术、神经外科手术和心血管外科手术。它能够黏附于组织表面、减少出血并促进癒合，使其成为外科医生和医疗保健专业人员的宝贵工具。

纤维蛋白胶在医学领域的重要性不仅在于其黏合性能。纤维蛋白胶提供了一种微创解决方案来控制出血并促进组织癒合，减少了某些手术中对传统缝线和钉书钉的需求。此外，纤维蛋白胶可以将抗生素和生长因子等治疗剂直接输送到伤口部位，进一步增强其效能。随着对先进伤口护理和手术解决方案的需求不断增长，纤维蛋白胶在改善患者预后和手术效率方面的作用越来越受到认可。

纤维蛋白胶的主要应用和医疗保健需求是什么？

纤维蛋白胶广泛应用于各种医疗领域，满足医疗专业人员和患者的需求。在一般外科手术中，纤维蛋白胶通常用于控制肝切除术、胃切除术和结直肠切除术等手术期间的出血。可以快速止血，减少失血，降低併发症的风险，最终改善手术效果。在这些应用中使用纤维蛋白胶也有助于延长恢復时间并最大限度地减少术后疼痛，使患者和医疗机构都受益。

在整形外科手术中，纤维蛋白胶用于支持组织癒合并降低关节关节重建、韧带修復和骨折融合术等手术后併发症的风险。纤维蛋白胶可促进组织黏合并改善癒合过程，有助于患者更快康復并改善功能结果。随着外科医生寻求有效的解决方案来优化手术结果，其在肌肉骨骼损伤管理中的应用变得越来越普遍。

神经外科是纤维蛋白胶越来越受欢迎的另一个领域。这些产品用于控制颅脑和脊椎手术期间的出血，因为控制出血至关重要。纤维蛋白胶的生物相容性和黏合特性使其非常适合在精细的手术环境中使用，可有效控制出血而不损害周围组织。随着神经外科技术的进步，纤维蛋白胶的采用预计会增加。

纤维蛋白胶也用于心血管外科手术，特别是心臟绕道手术和瓣膜置换术。纤维蛋白胶可在传统缝合困难的部位提供有效止血，提高手术精确度并降低术后出血风险。微创心血管手术的需求不断增长，进一步增加了对有效促进伤口缝合和癒合的纤维蛋白胶创新解决方案的需求。

此外，人们正在研究纤维蛋白胶在伤口护理和组织工程的新应用。纤维蛋白胶因其在慢性伤口管理中的应用而受到关注，因为它们可以透过提供对组织再生的支持环境来促进难以治疗的伤口的癒合。随着研究的不断深入，新的应用将会被发现，扩大纤维蛋白胶在医疗保健产业的潜力，以满足更广泛的医疗需求。

科技进步如何影响纤维蛋白胶市场？

由于产品配方的改进、应用技术的改进和临床应用的扩大，技术进步正在对纤维蛋白胶市场产生重大影响。一个显着的发展是纤维蛋白胶配方的创新，旨在提高性能和易用性。製造商致力于製造具有优化黏度和流动特性的纤维蛋白胶，以便更容易应用并提高对组织表面的黏附性。这些进步使得外科医生更容易使用纤维蛋白胶，并使其在各种外科手术中得到应用。

此外，对新输送系统的研究正在扩大纤维蛋白胶的潜在应用。施用器和其他先进输送方法的发展使得能够精确、有针对性地应用纤维蛋白胶，从而提高其在各种临床环境中的有效性。这些交付创新使医疗保健提供者能够将纤维蛋白胶用于更广泛的程序，从而确保最佳的性能和结果。

将生物相容性和生物活性成分整合到纤维蛋白胶配方中是影响市场的另一个趋势。製造商正在探索将生长因子、抗菌剂和其他治疗添加剂加入纤维蛋白胶中，以增强其癒合性能。这些进展旨在透过促进组织再生和降低感染风险来改善患者的治疗效果。随着这些增强功能的好处变得越来越明显，对多功能纤维蛋白胶的需求预计会增加。

此外，微创手术技术的兴起正在影响纤维蛋白胶市场。随着外科医生采用更多微创手术，对有效的伤口缝合解决方案来支持这些手术的需求也日益增加。纤维蛋白胶是微创手术的首选，因为它们提供了一种无需使用传统缝合线即可促进止血和癒合的合适选择。

纤维蛋白胶市场也受到以病人安全和法规遵循为重点的创新的推动。製造商投资研究和测试以确保其产品符合最高的安全性和有效性标准。专注于开发具有明确临床疗效和安全性的纤维蛋白胶对于获得医疗保健提供者和监管机构的认可至关重要。对品质和安全的承诺有望提高纤维蛋白胶在医学界的声誉。

推动纤维蛋白胶市场成长的因素是什么？

纤维蛋白胶市场的成长受到多种关键因素的推动，例如外科手术的增加、对先进创伤护理解决方案的需求不断增长以及对减少术后併发症的关注。其中一个主要因素是全球外科手术数量的增加。随着医疗保健产业的不断扩大，对有效止血和伤口缝合解决方案的需求日益增加。纤维蛋白胶是控制出血和促进癒合的有效选择，已成为各种外科专业的必需品。

对先进伤口护理解决方案的需求不断增长也是推动市场成长的关键因素。随着慢性伤口、压疮和手术部位感染的增加，医疗保健提供者正在寻求创新方法来加速创伤治疗并减少併发症。纤维蛋白胶具有支持组织修復和降低感染风险的能力，在伤口处理中越来越受欢迎。对病人安全和改善临床结果的关注推动了对有效创伤护理产品的需求增加。

此外，越来越重视减少术后併发症和延长恢復时间也对纤维蛋白胶市场产生了影响。医疗保健提供者认识到使用纤维蛋白胶的好处：它们可以减少出血，促进癒合，并最大限度地减少额外干预的需要。由于医院和外科中心优先考虑患者的治疗结果和效率，预计纤维蛋白胶在外科实践中的应用将会增加。

此外，手术技术和技术的进步促进了纤维蛋白胶被纳入常规手术实践中。随着微创手术变得越来越普遍，对有效的伤口缝合解决方案的需求也日益增加，以适应这些技术。纤维蛋白胶提供了一种无需使用传统缝合线即可促进止血和癒合的合适选择，从而有助于其在各种外科专业中的广泛应用。

最后，正在进行的研究和临床研究调查纤维蛋白胶在各种应用中的功效，正在推动市场成长。随着有关纤维蛋白胶在各种外科手术中的益处的新证据出现，医疗保健提供者可能会将这些产品纳入他们的实践中。越来越多的临床资料支持使用纤维蛋白胶，纤维蛋白胶可能会增加其在医学界的接受度和利用率。

总之，由于外科手术数量的增加、对先进创伤护理解决方案的需求不断增长以及对减少术后併发症的关注，纤维蛋白胶市场预计将显着增长。产品配方和交付方法的技术进步可能会进一步增加市场潜力。随着医疗保健提供者继续优先考虑患者安全和有效的伤口管理，预计未来几年对纤维蛋白胶的需求将会成长。

部分

类型（液体、贴片）；应用（心血管外科、整形外科、一般外科、移植外科、其他）；最终用途（医院、专科诊所、其他最终用途）

受访公司范例（值得关注的36家公司）

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP17257

Global Fibrin Sealants Market to Reach US$1.6 Billion by 2030

The global market for Fibrin Sealants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Fibrin Sealant Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Fibrin Sealant Patches segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$293.1 Million While China is Forecast to Grow at 9.1% CAGR

The Fibrin Sealants market in the U.S. is estimated at US$293.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$364.1 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Fibrin Sealants Market – Key Trends & Drivers Summarized

What Are Fibrin Sealants, And Why Are They Essential in Medical Applications?

Fibrin sealants are a type of biological adhesive used in various medical applications to promote wound healing and tissue repair. Composed of fibrinogen and thrombin, these sealants mimic the final stages of the blood coagulation process, facilitating the formation of a fibrin clot that effectively seals wounds and enhances hemostasis. Fibrin sealants are used in a wide range of surgical procedures, including general surgery, orthopedics, neurosurgery, and cardiovascular surgery. Their ability to adhere to tissue surfaces, control bleeding, and accelerate healing makes them a valuable tool for surgeons and healthcare professionals.

The significance of fibrin sealants in medical practice extends beyond their adhesive properties. They provide a minimally invasive solution for managing bleeding and promoting tissue healing, reducing the need for traditional sutures and staples in certain procedures. Additionally, fibrin sealants can deliver therapeutic agents, such as antibiotics or growth factors, directly to the wound site, further enhancing their effectiveness. As the demand for advanced wound care and surgical solutions continues to rise, the role of fibrin sealants in improving patient outcomes and surgical efficiency is increasingly recognized.

What Are the Main Applications of Fibrin Sealants, And How Do They Cater to Healthcare Needs?

Fibrin sealants have a wide range of applications across various medical fields, catering to the specific needs of healthcare providers and patients. In general surgery, fibrin sealants are commonly used to control bleeding during procedures such as liver resections, gastric surgeries, and colorectal surgeries. Their ability to provide rapid hemostasis helps reduce blood loss and the risk of complications, ultimately improving surgical outcomes. The use of fibrin sealants in these applications also enhances recovery times and minimizes postoperative pain, benefiting both patients and healthcare facilities.

In orthopedic surgery, fibrin sealants are employed to support tissue healing and reduce the risk of complications following procedures such as joint replacements, ligament repairs, and fracture fixations. By promoting the adhesion of tissues and enhancing the healing process, fibrin sealants contribute to faster recovery and improved functional outcomes for patients. Their application in managing musculoskeletal injuries is becoming increasingly common as surgeons seek effective solutions to optimize surgical results.

Neurosurgery is another area where fibrin sealants are gaining traction. They are used to manage bleeding during cranial and spinal procedures, where controlling hemorrhage is critical. The biocompatibility and adhesive properties of fibrin sealants make them ideal for use in delicate surgical environments, ensuring that bleeding is effectively managed without compromising surrounding tissues. As advancements in neurosurgical techniques continue, the adoption of fibrin sealants is expected to increase.

Fibrin sealants are also used in cardiovascular surgery, particularly in procedures involving cardiac bypass and valve replacement. They provide effective hemostasis in areas where traditional sutures may be challenging to apply, enhancing surgical precision and reducing the risk of postoperative bleeding. The growing demand for minimally invasive cardiovascular procedures is further driving the need for innovative solutions like fibrin sealants that promote effective wound closure and healing.

Furthermore, fibrin sealants are being explored in emerging applications, such as wound care and tissue engineering. Their use in chronic wound management is gaining attention, as they can enhance healing in difficult-to-treat wounds by providing a supportive environment for tissue regeneration. As research continues to uncover new applications, the potential for fibrin sealants in the healthcare industry will likely expand, catering to a broader range of medical needs.

How Are Technological Advancements Impacting the Fibrin Sealants Market?

Technological advancements are significantly influencing the fibrin sealants market by improving product formulations, enhancing application techniques, and expanding their clinical use. One notable development is the innovation in fibrin sealant formulations, which aim to enhance their performance and usability. Manufacturers are focusing on creating fibrin sealants with optimized viscosity and flow characteristics, enabling easier application and improved adhesion to tissue surfaces. These advancements make fibrin sealants more user-friendly for surgeons, contributing to their growing adoption in various surgical procedures.

Additionally, research into novel delivery systems is expanding the potential applications of fibrin sealants. The development of spray applicators and other advanced delivery methods allows for precise and targeted application of fibrin sealants, improving their effectiveness in diverse clinical settings. These delivery innovations enable healthcare providers to use fibrin sealants in a broader range of procedures, ensuring optimal performance and outcomes.

The integration of biocompatible and bioactive components into fibrin sealant formulations is another trend impacting the market. Manufacturers are exploring the incorporation of growth factors, antimicrobial agents, and other therapeutic additives into fibrin sealants to enhance their healing properties. These advancements are aimed at improving patient outcomes by promoting tissue regeneration and reducing the risk of infection. As research continues to uncover the benefits of these enhancements, the demand for multifunctional fibrin sealants is expected to grow.

Moreover, the rise of minimally invasive surgical techniques is influencing the fibrin sealants market. As surgeons increasingly adopt less invasive approaches to procedures, the need for effective wound closure solutions that align with these techniques is rising. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, making them a preferred choice in minimally invasive surgeries.

The emphasis on patient safety and regulatory compliance is also driving innovation in the fibrin sealants market. Manufacturers are investing in research and testing to ensure that their products meet the highest safety and efficacy standards. The focus on developing fibrin sealants with proven clinical benefits and safety profiles is essential for gaining acceptance among healthcare providers and regulatory bodies. This commitment to quality and safety is expected to enhance the reputation of fibrin sealants in the medical community.

What Is Driving the Growth in the Fibrin Sealants Market?

The growth in the fibrin sealants market is driven by several key factors, including increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. One of the primary drivers is the growing number of surgical procedures performed globally. As the healthcare industry continues to expand, the demand for effective hemostatic agents and wound closure solutions is increasing. Fibrin sealants provide an effective option for controlling bleeding and promoting healing, making them essential in various surgical specialties.

The rising demand for advanced wound care solutions is another significant factor contributing to market growth. With an increasing prevalence of chronic wounds, pressure ulcers, and surgical site infections, healthcare providers are seeking innovative approaches to enhance wound healing and reduce complications. Fibrin sealants, with their ability to support tissue repair and reduce infection risks, are becoming increasingly popular in wound management. The ongoing emphasis on patient safety and improved clinical outcomes is further driving the demand for effective wound care products.

Additionally, the focus on minimizing postoperative complications and enhancing recovery times is influencing the fibrin sealants market. Healthcare providers are recognizing the benefits of using fibrin sealants in reducing bleeding, promoting healing, and minimizing the need for additional interventions. As hospitals and surgical centers prioritize patient outcomes and efficiency, the adoption of fibrin sealants in surgical practice is expected to grow.

Moreover, advancements in surgical techniques and technology are facilitating the integration of fibrin sealants into routine surgical practice. As minimally invasive procedures gain popularity, the need for effective wound closure solutions that align with these techniques becomes increasingly important. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, contributing to their growing use in various surgical specialties.

Finally, ongoing research and clinical studies investigating the efficacy of fibrin sealants in different applications are driving market growth. As new evidence emerges regarding the benefits of fibrin sealants in various surgical procedures, healthcare providers are likely to incorporate these products into their practice. The expanding body of clinical data supporting the use of fibrin sealants will enhance their acceptance and utilization in the medical community.

In conclusion, the fibrin sealants market is poised for significant growth driven by increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. Technological advancements in product formulations and delivery methods will further enhance the market's potential. As healthcare providers continue to prioritize patient safety and effective wound management, the demand for fibrin sealants is expected to flourish in the coming years.

SCOPE OF STUDY:

The report analyzes the Fibrin Sealants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Liquid, Patches); Application (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery, Other Applications); End-Use (Hospitals, Specialty Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Fibrin Sealants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Adoption of Fibrin Sealants in Hemostasis and Wound Healing Expands Addressable Market
    • Surge in Demand for Fibrin Sealants in Minimally Invasive Surgeries Fuels Market Growth
    • Growing Focus on Fibrin Sealants for Reducing Blood Loss and Postoperative Complications Strengthens Business Case
    • Surge in Adoption of Fibrin Sealants in Orthopedic and Trauma Surgeries Expands Market Opportunities
    • Growing Demand for Fibrin Sealants in Dental and Maxillofacial Surgeries Expands Addressable Market
    • Surge in Adoption of Fibrin Sealants in Plastic and Reconstructive Surgeries Expands Market Opportunities
    • Technological Advancements in Fibrin Sealants for Enhanced Biocompatibility Propel Market Growth
    • Growing Use of Fibrin Sealants in Neurosurgery and Spinal Procedures Strengthens Business Case
    • Rising Adoption of Fibrin Sealants in Emerging Markets with Expanding Healthcare Infrastructure Sets the Stage for Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Cardiovascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Transplant Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Fibrin Sealants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION